Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6479
pubmed:dateCreated
1985-7-10
pubmed:abstractText
Hepatitis D virus (delta agent) markers were present in 111 (36%) of 308 intravenous drug abusers who were positive for hepatitis B surface antigen (HBsAg), 52 of these having hepatitis D virus antigenaemia. IgM antibody to hepatitis B core antigen (anti-HBc IgM) was present in 92 out of 95 subjects tested, indicating that hepatitis D virus and hepatitis B virus infections had been acquired simultaneously. Hepatitis D virus markers were present in three out of four patients with fulminant hepatitis, and in 80 of 223 (36%) with mild or moderate hepatitis compared with four of 29 (14%) of those who were asymptomatic. These proportional differences were significant (p less than 0.001). Hepatitis D virus markers were present in twice as many patients positive for anti-HBc IgM requiring admission to hospital with acute hepatitis compared with outpatients attending a drug treatment centre. Tests on one patient showed complete disappearance of HBsAg, but hepatitis D antigen (HDAg or delta antigen) and hepatitis B e antigen (HBeAg) were still present in serum samples. All five patients with chronic active hepatitis had hepatitis D antibody (anti-HD) compared with seven of 24 (29%) with chronic persistent hepatitis (p = 0.008). Blocking anti-HD persisted for long periods after simultaneous infections with hepatitis B virus and hepatitis D virus but at lower titres than in patients with chronic liver disease.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/3922501-6127458, http://linkedlifedata.com/resource/pubmed/commentcorrection/3922501-6132106, http://linkedlifedata.com/resource/pubmed/commentcorrection/3922501-6134938, http://linkedlifedata.com/resource/pubmed/commentcorrection/3922501-6137731, http://linkedlifedata.com/resource/pubmed/commentcorrection/3922501-6138670, http://linkedlifedata.com/resource/pubmed/commentcorrection/3922501-6175733, http://linkedlifedata.com/resource/pubmed/commentcorrection/3922501-6363622, http://linkedlifedata.com/resource/pubmed/commentcorrection/3922501-6401506, http://linkedlifedata.com/resource/pubmed/commentcorrection/3922501-6404423, http://linkedlifedata.com/resource/pubmed/commentcorrection/3922501-6417045, http://linkedlifedata.com/resource/pubmed/commentcorrection/3922501-6474132, http://linkedlifedata.com/resource/pubmed/commentcorrection/3922501-6696355, http://linkedlifedata.com/resource/pubmed/commentcorrection/3922501-6736942, http://linkedlifedata.com/resource/pubmed/commentcorrection/3922501-6829551, http://linkedlifedata.com/resource/pubmed/commentcorrection/3922501-6838075, http://linkedlifedata.com/resource/pubmed/commentcorrection/3922501-6852449, http://linkedlifedata.com/resource/pubmed/commentcorrection/3922501-7021574, http://linkedlifedata.com/resource/pubmed/commentcorrection/3922501-7024305, http://linkedlifedata.com/resource/pubmed/commentcorrection/3922501-7152867, http://linkedlifedata.com/resource/pubmed/commentcorrection/3922501-91776
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0267-0623
pubmed:author
pubmed:issnType
Print
pubmed:day
11
pubmed:volume
290
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1377-80
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1985
pubmed:articleTitle
Increased severity and morbidity of acute hepatitis in drug abusers with simultaneously acquired hepatitis B and hepatitis D virus infections.
pubmed:publicationType
Journal Article